XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Income per Common Share Attributable to Magellan Health, Inc.
9 Months Ended
Sep. 30, 2018
Net Income per Common Share Attributable to Magellan Health, Inc.  
Net Income per Common Share Attributable to Magellan Health, Inc.

NOTE B—Net Income per Common Share Attributable to Magellan Health, Inc.

The following table reconciles income attributable to common shareholders (numerator) and shares (denominator) used in the computations of net income per share attributable to common shareholders (in thousands, except per share data) for the three and nine months ended September 30:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 

 

September 30, 

 

 

    

2017

    

2018

    

2017

    

2018

    

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Magellan

 

$

32,451

 

$

27,145

 

$

55,698

 

$

52,148

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding—basic

 

 

23,282

 

 

24,433

 

 

23,135

 

 

24,451

 

Common stock equivalents—stock options

 

 

572

 

 

413

 

 

485

 

 

630

 

Common stock equivalents—RSAs

 

 

483

 

 

 2

 

 

461

 

 

19

 

Common stock equivalents—RSUs

 

 

61

 

 

26

 

 

46

 

 

42

 

Common stock equivalents—PSUs

 

 

162

 

 

49

 

 

111

 

 

171

 

Common stock equivalents—employee stock purchase plan

 

 

 3

 

 

 5

 

 

 3

 

 

 3

 

Weighted average number of common shares outstanding—diluted

 

 

24,563

 

 

24,928

 

 

24,241

 

 

25,316

 

Net income attributable to Magellan per common share—basic

 

$

1.39

 

$

1.11

 

$

2.41

 

$

2.13

 

Net income attributable to Magellan per common share—diluted

 

$

1.32

 

$

1.09

 

$

2.30

 

$

2.06

 

The weighted average number of common shares outstanding for the nine months ended September 30, 2017 and 2018 were calculated using outstanding shares of the Company’s common stock. Common stock equivalents included in the calculation of diluted weighted average common shares outstanding for the nine months ended September 30, 2017 and 2018 represent stock options to purchase shares of the Company’s common stock, RSAs, RSUs, PSUs and stock purchased under the Employee Stock Purchase Plan.

The Company had additional potential dilutive securities outstanding representing 0.4 million and 0.6 million options for the three and nine months ended September 30, 2017, respectively, and 0.6 million and 0.4 million options for the three and nine months ended September 30, 2018, respectively, that were not included in the computation of dilutive securities because they were anti-dilutive for the period. Had these shares not been anti-dilutive, all of these shares would not have been included in the net income attributable to common shareholder per common share calculation as the Company uses the treasury stock method of calculating diluted shares.